Test Code MPLVS MPL Exon 10 Mutation Detection, Varies
Reporting Name
MPL Exon 10 Mutation Detection, VPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Aiding in the distinction between a reactive cytosis and a myeloproliferative neoplasm
Method Name
Sanger Sequencing
Specimen Required
Submit only 1 of the following specimens:
Specimen Type: Peripheral blood
Container/Tube: Lavender top (EDTA) or yellow top (ACD)
Specimen Volume: 3 mL
Collections Instructions:
1. Invert several times to mix blood.
2. Send specimen in original tube. Do not aliquot.
3. Label specimen as blood.
Specimen Stability: Ambient (preferred)/Refrigerate
Specimen Type: Bone marrow
Container/Tube: Lavender top (EDTA) or yellow top (ACD)
Specimen Volume: 2 mL
Collections Instructions:
1. Invert several times to mix bone marrow.
2. Send specimens in original tube. Do not aliquot.
3. Label specimen as bone marrow.
Specimen Stability: Ambient (preferred)/Refrigerate
Specimen Type: Extracted DNA from blood or bone marrow
Container/Tube: 1.5- to 2- mL tube
Specimen Volume: Entire specimen
Collection Instructions: Label specimen as extracted DNA from blood or bone marrow and provide indication of volume and concentration of DNA.
Specimen Stability Information: Frozen (preferred)/Refrigerated/Ambient
Specimen Type
VariesSpecimen Minimum Volume
Blood, Bone marrow: 0.5 mL; Extracted DNA: 50 mcL at 20 ng/mcL concentration
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Varies | 7 days |
Reject Due To
Gross hemolysis | Reject |
Bone marrow biopsies Slides paraffin shavings Moderately to severely clotted |
Reject |
Reference Values
An interpretive report will be provided.
Interpretation
The results will be reported as 1 of 2 states:
-Negative for MPL exon 10 variant
-Positive for MPL exon 10 variant
If the result is positive, a description of the variant at the nucleotide level and the altered protein sequence is reported.
Positive variant status is highly suggestive of a myeloproliferative neoplasm but must be correlated with clinical and other laboratory features for a definitive diagnosis. Negative variant status does not exclude the presence of a myeloproliferative or other neoplasm.
Day(s) Performed
Monday through Friday
Report Available
5 to 8 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81339-MPL (myeloproliferative leukemia virus oncogene, thrombopoietin receptor, TPOR) (eg, myeloproliferative disorder), exon 10 sequence
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
MPLVS | MPL Exon 10 Mutation Detection, V | 62948-5 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
MP051 | Specimen Type | 31208-2 |
602600 | Interpretation | 69047-9 |
602601 | Signing Pathologist | 19139-5 |
Forms
If not ordering electronically, complete, print, and send a Hematopathology/Cytogenetics Test Request (T726) with the specimen.
Testing Algorithm
For more information see:
-Myeloproliferative Neoplasm: A Diagnostic Approach to Bone Marrow Evaluation
-Myeloproliferative Neoplasm: A Diagnostic Approach to Peripheral Blood Evaluation